In the News


MASH treatments compared in network meta-analysis

Pegozafermin, cilofexor plus firsocostat, and cilofexor plus selonsertib appear to be the most effective interventions for fibrosis regression and resolution of metabolic dysfunction-associated steatohepatitis (MASH), a systematic review and network meta-analysis found.

GLP-1 receptor agonists negatively impact colonoscopy bowel preparation, review finds

Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists were more than twice as likely to experience inadequate bowel preparation for colonoscopy than those not taking the medications, a meta-analysis found.

Machine learning model predicted mortality among malnourished inpatients with IBD

Integrating such models into clinical practice could improve identification of inflammatory bowel disease (IBD) patients at risk for malnutrition and potentially reduce their mortality by prompting earlier intervention, according to the authors of a new study.

MKSAP Quiz: 5-day history of nonbloody watery diarrhea

A 21-year-old man is evaluated for a 5-day history of nonbloody watery diarrhea that began after international travel. Following a physical exam, what is the most appropriate next step in management?

Spotlight on HCV treatment programs

Studies of hepatitis C virus (HCV) found that patients in Kentucky were less likely to be treated for HCV if they were receiving medication for opioid use disorder, that a mobile free clinic in Alabama successfully treated patients with a single in-person visit, and HCV treatment rates have increased in Israel over the past decade.

Handling H. pylori resistance

Antibiotic resistance and a new guideline will change how physicians manage Helicobacter pylori.

In the Clinic: Hemochromatosis

An In the Clinic article provided an overview of hemochromatosis, an inheritable condition that mainly affects White populations of European descent.